Stock Price Quote

ASTRAZENECA PHARMA INDIA LTD.

NSE : ASTRAZENBSE : 506820ISIN CODE : INE203A01020Industry : Pharmaceuticals & DrugsHouse : Astrazeneca Pharma India - MNC
BSE3347.7022.15 (+0.67 %)
PREV CLOSE ( ) 3325.55
OPEN PRICE ( ) 3311.95
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 299
TODAY'S LOW / HIGH ( )3305.55 3347.70
52 WK LOW / HIGH ( )2437.75 3619.7
NSE3348.6022.7 (+0.68 %)
PREV CLOSE( ) 3325.90
OPEN PRICE ( ) 3325.00
BID PRICE (QTY) 3328.00 (2)
OFFER PRICE (QTY) 3348.60 (2)
VOLUME 4112
TODAY'S LOW / HIGH( ) 3303.75 3350.00
52 WK LOW / HIGH ( )2445.7 3620
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 11-07 1979
Management Info
Narayan K Seshadri - Chairman Gagandeep Singh Bedi - Managing Director
Registered Office

Address Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring Road,
Bengaluru,
Karnataka-560045

Phone 080 6774 8000

Email comp.secy@astrazeneca.com

Website www.astrazenecaindia.com/india

Registrars Details
Integrated Registrary Management Services Pvt Ltd.-(Formerly Integrated Enterprises (India) Ltd)
30, Ramana Residency,4th Cross, Sampige Road,Malleswaram,Bangalore
Listing : BSE, NSE, MCX

NEWS

28Nov Astrazeneca Pharma India Limited Has
Additional/ Extended IndicationPlease find the enclosed letter of the Co..
28Nov AstraZeneca Pharma gets import, market
AstraZeneca Pharma has received an Import and Market permission in Form..
26Nov AstraZeneca Pharma India informs about
AstraZeneca Pharma India has informed that, AstraZeneca Pharma India has..
19Nov Astrazeneca Pharma India informs about
Pursuant to Regulation 39(3) and other applicable regulations of SEBI (L..
01Nov Increase In Volume
This has reference to your email dated October 28, 2022 bearing referenc..

Financials

in Millions
QTR Sep 22 ANNUAL 22
Net Profit325.66615.94
Gross Profit 440.71 830.37
Operating Profit 475.21009.33
Net Sales 2361.278056

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Procter&Gamble Healt (BSE)
peergroup  4159.50 (1.65%)
M.Cap ( in Cr)6878.78
RPG Life Sciences (BSE)
peergroup  911.80 (4.76%)
M.Cap ( in Cr)1510.26
Samrat Pharmachem (BSE)
peergroup  827.45 (5.00%)
M.Cap ( in Cr)255.66
Hikal (BSE)
peergroup  381.10 (8.56%)
M.Cap ( in Cr)4724.88
Abbott India (BSE)
peergroup  20233.00 (0.13%)
M.Cap ( in Cr)42965.34

Shareholding Pattern

PROMOTERS 75%
NON-INSTITUTION 21.18%
MUTUAL FUNDS/UTI 1.09%
FI/BANKS/INSURANCE 0.03%
GOVERNMENT 0%
FII 0%

About Astrazeneca Pharma India Ltd.

Astrazeneca Pharma India Ltd. was incorporated in the year 1979. Its today's share price is 3347.7. Its current market capitalisation stands at Rs 8276.13 Cr. In the latest quarter, company has reported Gross Sales of Rs. 8094.5 Cr and Total Income of Rs.8203.6 Cr. The company's management includes Manasa R, Rajesh Marwaha, Gagandeep Singh Bedi, Weiying Sarah Wang, Ankush Nandra, Shilpa Shridhar Divekar, Revathy Ashok, Narayan K Seshadri.

It is listed on the BSE with a BSE Code of 506820 , NSE with an NSE Symbol of ASTRAZEN and ISIN of INE203A01020. It's Registered office is at Block N1, 12th Floor,Manyata Embassy Business Park,Rachenahalli, Outer Ring RoadBengaluru-560045, Karnataka. Their Registrars are K FIN Technologies Ltd.-(Karvy Fintech Pvt Ltd.) It's auditors are AF Ferguson & Co, Bharat S Raut & Co, BSR & Co, BSR & Co LLP, Price Waterhouse & Co, Price Waterhouse & Co Chartered Accountants LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)